January 20, 2014 | Israeli biopharmaceutical company RedHill Biopharma has announced that it has raised $20 million over two consecutive weeks. The company, which acquires drugs and treatments in late clinical trial stages and then finalizes development, raised some of the money from VCs and some in the form of a share offering.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments